Study reveals that gut microbial dysbiosis and frequent antibiotic use are key risk factors for recurrent urinary tract infections (UTIs) in women, emphasizing the importance of a healthy lifestyle and dietary supplements to prevent UTIs.
Jazz’s KRAS deal with Redx; Alto Neuroscience upsizes IPO
Plus, news about PepGen and Jasper Therapeutics: Jazz Pharmaceuticals buys Redx Pharma’s KRAS inhibitors: The company is paying Redx $10 million upfront, with milestones up